JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bach-Gansmo, T.
Right arrow Articles by Tobin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bach-Gansmo, T.
Right arrow Articles by Tobin, D.

Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692

Tore Bach-Gansmo1, Rimma Danielsson2, Ariel Saracco2, Brigitte Wilczek2, Trond V. Bogsrud1, Anne Fangberget1, Åse Tangerud3 and Derek Tobin4

1 Rikshospitalet–Radiumhospitalet Medical Center, Oslo, Norway; 2 Division of Radiology, Karolinska Institutet, Stockholm, Sweden; 3 Asker and Bærum Hospital, Bærum, Norway; and 4 GE Healthcare, Oslo, Norway


Figure 1
View larger version (102K):

[in a new window]
 
FIGURE 1.  Patient 1: Infiltrative ductal carcinoma (8 mm). Lateral projection.

 

Figure 2
View larger version (154K):

[in a new window]
 
FIGURE 2.  Patient 3: Infiltrative ductal carcinoma (10 mm), with surrounding ductal carcinoma in situ. Frontal projection.

 

Figure 3
View larger version (116K):

[in a new window]
 
FIGURE 3.  Patient 14: Large infiltrative ductal carcinoma (35 mm) (large arrow) with uptake in axillary lymph nodes (small arrow). Frontal projection.

 

Figure 4
View larger version (54K):

[in a new window]
 
FIGURE 4.  Patient 10: Diffuse, heterogeneous uptake in fibrocystic disease, with no focal pathology. Lateral projection.

 

Figure 5
View larger version (110K):

[in a new window]
 
FIGURE 5.  Patient 19: Intense uptake in infected cyst. SPECT, coronal projection.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.